17-N-Allylamino-17-demethoxygeldanamycin

From Self-sufficiency
Jump to: navigation, search
17-N-Allylamino-17-demethoxygeldanamycin
File:17-N-Allylamino-17-demethoxygeldanamycin.svg
style="background: #F8EABA; text-align: center;" colspan="2" | Identifiers
CAS number 75747-14-7
PubChem 6440175
ChemSpider 21106220
SMILES Script error: No such module "collapsible list".
InChI Script error: No such module "collapsible list".
InChI key AYUNIORJHRXIBJ-TXHRRWQRBY
style="background: #F8EABA; text-align: center;" colspan="2" | Properties
Molecular formula C31H43N3O8
Molar mass 585.689 g/mol
Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa)
Infobox references

17-N-Allylamino-17-demethoxygeldanamycin is a substance that is being studied in the treatment of cancer, specific young patients with certain types of leukemia or solid tumors, especially kidney tumors. It works by targeting Hsp90, which is expressed in those tumors. As of June 2005, 17-N-allylamino-17-demethoxygeldanamycin is undergoing Phase 1 and Phase 2 clinical trials. It belongs to the family of drugs called antitumor antibiotics.

References


External links